Leakage of R&D Information and Trade Secrets
First written in FY2023. 1 of 3 entries say "Restated". Latest entry: FY2025.
K Pharma moved to the "Worse" side of this theme in 2026.
0 other companies' latest entry also says "Worsened".
- FY2025WorsenedAnnual report
「Information may be leaked through social media and other channels or as a result of sophisticated cyberattacks, including unauthorized access and ransomware attacks.」
In addition to conventional leakage risks, the company specifically identifies unauthorized access and ransomware as sophisticated cyber threats. - FY2024RestatedAnnual report
「To prevent unauthorized external leakage of this information, we have established information-security rules and are strengthening our internal management system through employee training on information handling and access controls.」
The company reiterates the risk of leakage of research and development information and trade secrets and its responses through rules, training and access controls. - FY2023First statedAnnual report
「We hold technology, know-how and other information related to research and development, as well as confidential business information. To prevent unauthorized external leakage of this information, we have established information-security rules and」
The company identifies leakage of technology, know-how and confidential information as a risk and responds through rules, training and access controls.